Home

Climate Change Project

Table of Contents

Courses

Search


Drug Regulation

Supreme Court Preview - United States v. Oakland Cannabis Buyers' Cooperative, 190 F.3d 1109 (9th Cir. 1999)

The Supreme Court has accepted this case for review.  As reviewed in a previous issue of LMP, this case arose from war between California and the federal government over the medical use of marijuana.  A citizen initiative put a proposition on the ballot to legalize the medical use of marijuana.  When the initiative passed, the language of the proposition was found to be so broad that it essentially legalized cannabis use, as long as the user made some claim as to medical necessity. Had this been a narrowly drafted exception for medical necessity, as in the Alaska medical marijuana use law discussed in Rollins v. Ulmer, it would not have provoked the same confrontation with the federal government, which sees cannabis use as a violation of the Comprehensive Drug Abuse Prevention and Control Act of 1970 (the "Controlled Substances Act").  In California, marijuana was dispensed in poorly regulated private clubs which had little incentive to control who was provided marijuana.  The Department of Justice (DOJ) wanted to stop the distribution of marijuana, but was sensitive to the adverse publicity that would follow the prosecution of the People with AIDS and cancer sufferers mixed in with the other customers.  The government sought an injunction against the Oakland Cannabis Buyers' Cooperative and others (collectively "OCBC") to prevent their distribution of cannabis.

The district court enjoined the distribution of marijuana as a violation of the Controlled Substances Act.  The OCBC appealed, claiming that the injunction should not have been granted on grounds of a necessity defense to the Controlled Substances Act. (This is an attractive procedural device because it allows the necessity defense to be raised without the threat of jail time if it rejected.) The Ninth Circuit held that it would be proper to consider a medical necessity defense to the requested injunction, and instructed to district to reconsider its decision in light of precedent on the use of the necessity defense in other contexts.  Noting this decision, the district court reformed its injunction in U.S. v. Oakland Cannabis Buyers' Co-op., 2000 WL 1517166 (N.D.Cal. Jul 17, 2000).  The court continued its previous injunction against the cultivation and distribution of marijuana, but added this critical exception:

"The foregoing injunction does not apply to the distribution of cannabis by the Oakland Cannabis Buyers' Cooperative and Jeffrey Jones to patient-members who (1) suffer from a serious medical condition, (2) will suffer imminent harm if the patient-member does not have access to cannabis, (3) need cannabis for the treatment of the patient-member's medical condition, or need cannabis to alleviate the medical condition or symptoms associated with the medical condition, and (4) have no reasonable legal alternative to cannabis for the effective treatment or alleviation of the patient-member's medical condition or symptoms associated with the medical condition because the patient-member has tried all other legal alternatives to cannabis and the alternatives have been ineffective in treating or alleviating the patient-member's medical condition or symptoms associated with the medical condition, or the alternatives result in side effects which the patient-member cannot reasonably tolerate."

With this ruling the court set up a direct conflict with the federal Controlled Substances Act, which does not recognize a medical necessity exception to its prohibition of the distribution and use of marijuana outside federally regulated medical research programs.

The Climate Change and Public Health Law Site
The Best on the WWW Since 1995!
Copyright as to non-public domain materials
See DR-KATE.COM for home hurricane and disaster preparation
See WWW.EPR-ART.COM for photography of southern Louisiana and Hurricane Katrina
Professor Edward P. Richards, III, JD, MPH - Webmaster

Provide Website Feedback - https://www.lsu.edu/feedback
Privacy Statement - https://www.lsu.edu/privacy
Accessibility Statement - https://www.lsu.edu/accessibility